Payment overview · 2025
General Payments
$339.93
5 reported records · 5 companies
Healthcare provider profile · identity verified
Joy Sandy
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Primary Care · BURTON, MI · NPI 1013382357
Verified facts
What the public records show
CMS Open Payments records show Joy Sandy received $339.93 in general payments during 2025 across 5 reported records.
VERTEX PHARMACEUTICALS INCORPORATED accounted for 36.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Unresolved — no canonical attribution shown | $124.74 | 36.7% | 1 | 2025 |
| Madrigal Pharmaceuticals | Unresolved — no canonical attribution shown | $107.19 | 31.5% | 1 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $58.86 | 17.3% | 1 | 2025 |
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $33.21 | 9.8% | 1 | 2025 |
| Takeda Pharmaceuticals U.S.A., Inc. | Unresolved — no canonical attribution shown | $15.93 | 4.7% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $324.00 | 4 |
| Education | $15.93 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| JOURNAVX Normalized: journavx |
Drug | VERTEX PHARMACEUTICALS INCORPORATED | $124.74 | 1 | 2025 |
Source payment records
|
|||||
| REZDIFFRA Normalized: rezdiffra |
Drug | Madrigal Pharmaceuticals | $107.19 | 1 | 2025 |
Source payment records
|
|||||
| WATCHMAN FLX Normalized: watchman flx |
Device | Boston Scientific Corporation | $58.86 | 1 | 2025 |
Source payment records
|
|||||
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $33.21 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 685 | 190 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 560 | 168 |
| Amlodipine Besylate | Amlodipine Besylate | 452 | 134 |
| Lisinopril | Lisinopril | 445 | 128 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 386 | 153 |
| Omeprazole | Omeprazole | 359 | 91 |
| Levothyroxine Sodium | Levothyroxine Sodium | 332 | 101 |
| Hydrochlorothiazide | Hydrochlorothiazide | 271 | 82 |
| Metformin Hcl | Metformin Hcl | 266 | 75 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 260 | 58 |
| Metoprolol Tartrate | Metoprolol Tartrate | 253 | 66 |
| Ezetimibe | Ezetimibe | 239 | 62 |
| Ozempic | Semaglutide | 226 | 54 |
| Metoprolol Succinate | Metoprolol Succinate | 205 | 55 |
| Carvedilol | Carvedilol | 164 | 48 |
| Furosemide | Furosemide | 163 | 64 |
| Montelukast Sodium | Montelukast Sodium | 162 | 47 |
| Sertraline Hcl | Sertraline Hcl | 160 | 41 |
| Gabapentin | Gabapentin | 153 | 58 |
| Duloxetine Hcl | Duloxetine Hcl | 151 | 46 |
| Tamsulosin Hcl | Tamsulosin Hcl | 149 | 36 |
| Trazodone Hcl | Trazodone Hcl | 149 | 35 |
| Jardiance | Empagliflozin | 148 | 40 |
| Clopidogrel | Clopidogrel Bisulfate | 134 | 45 |
| Metformin Hcl Er | Metformin Hcl | 125 | 40 |
| Eliquis | Apixaban | 119 | 28 |
| Spironolactone | Spironolactone | 119 | 47 |
| Pantoprazole Sodium | Pantoprazole Sodium | 116 | 38 |
| Allopurinol | Allopurinol | 112 | 32 |
| Bupropion Xl | Bupropion Hcl | 112 | 35 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 107 | 30 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 107 | 41 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 105 | 31 |
| Potassium Chloride | Potassium Chloride | 105 | 35 |
| Losartan Potassium | Losartan Potassium | 101 | 33 |
| Tramadol Hcl | Tramadol Hcl | 100 | 24 |
| Buspirone Hcl | Buspirone Hcl | 97 | 22 |
| Prednisone | Prednisone | 93 | 62 |
| Fluticasone Propionate | Fluticasone Propionate | 88 | 40 |
| Famotidine | Famotidine | 87 | 30 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 85 | 27 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 82 | 21 |
| Escitalopram Oxalate | Escitalopram Oxalate | 79 | 32 |
| Telmisartan | Telmisartan | 79 | 30 |
| Trulicity | Dulaglutide | 76 | 18 |
| Pravastatin Sodium | Pravastatin Sodium | 74 | 24 |
| Quetiapine Fumarate | Quetiapine Fumarate | 74 | 16 |
| Risedronate Sodium | Risedronate Sodium | 71 | 18 |
| Simvastatin | Simvastatin | 70 | 22 |
| Mirtazapine | Mirtazapine | 68 | 20 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 67 | 24 |
| Hydralazine Hcl | Hydralazine Hcl | 66 | 18 |
| Meloxicam | Meloxicam | 66 | 22 |
| Diclofenac Sodium | Diclofenac Sodium | 65 | 28 |
| Ventolin Hfa | Albuterol Sulfate | 64 | 33 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 62 | 54 |
| Nitroglycerin | Nitroglycerin | 62 | 27 |
| Chlorthalidone | Chlorthalidone | 56 | 19 |
| Alprazolam | Alprazolam | 55 | 13 |
| Pregabalin | Pregabalin | 54 | 21 |
| Alendronate Sodium | Alendronate Sodium | 52 | 14 |
| Doxycycline Hyclate | Doxycycline Hyclate | 52 | 45 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 51 | 13 |
| Entresto | Sacubitril/Valsartan | 51 | 19 |
| Clonazepam | Clonazepam | 49 | 15 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 48 | 15 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 47 | 15 |
| Roflumilast | Roflumilast | 47 | 11 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 45 | 12 |
| Benazepril Hcl | Benazepril Hcl | 45 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 44 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 44 | 11 |
| Memantine Hcl | Memantine Hcl | 44 | 13 |
| Myrbetriq | Mirabegron | 44 | 14 |
| Fluoxetine Hcl | Fluoxetine Hcl | 40 | 15 |
| Lamotrigine | Lamotrigine | 40 | 13 |
| Aripiprazole | Aripiprazole | 39 | 16 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 39 | 28 |
| Symbicort | Budesonide/Formoterol Fumarate | 39 | 22 |
| Topiramate | Topiramate | 39 | 17 |
| Dicyclomine Hcl | Dicyclomine Hcl | 38 | 13 |
| Hydrocortisone | Hydrocortisone | 38 | 12 |
| Novolog Flexpen | Insulin Aspart | 38 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 37 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 36 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 36 | 17 |
| Valsartan | Valsartan | 36 | 16 |
| Xarelto | Rivaroxaban | 36 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 35 | 11 |
| Finasteride | Finasteride | 35 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 34 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 34 | 18 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 33 | 13 |
| Valacyclovir | Valacyclovir Hcl | 32 | 15 |
| Atenolol | Atenolol | 31 | 11 |
| Donepezil Hcl | Donepezil Hcl | 31 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 31 | suppressed |
| Torsemide | Torsemide | 31 | 13 |
| Propranolol Hcl | Propranolol Hcl | 30 | suppressed |
| Cephalexin | Cephalexin | 29 | 26 |
| Ondansetron Hcl | Ondansetron Hcl | 29 | 15 |
| Glipizide | Glipizide | 28 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 28 | suppressed |
| Azithromycin | Azithromycin | 27 | 18 |
| Fluconazole | Fluconazole | 27 | 18 |
| Methylprednisolone | Methylprednisolone | 27 | 23 |
| Doxepin Hcl | Doxepin Hcl | 26 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 26 | 13 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 25 | 11 |
| Ibuprofen | Ibuprofen | 25 | 17 |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 25 | suppressed |
| Mounjaro | Tirzepatide | 24 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 24 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 23 | suppressed |
| Lorazepam | Lorazepam | 23 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 23 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 23 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 22 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 21 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 21 | suppressed |
| Buprenorphine | Buprenorphine | 20 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 20 | suppressed |
| Levetiracetam | Levetiracetam | 20 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Bumetanide | Bumetanide | 19 | suppressed |
| Calcitriol | Calcitriol | 19 | suppressed |
| Colchicine | Colchicine | 19 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 19 | suppressed |
| Lovastatin | Lovastatin | 19 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Primidone | Primidone | 19 | suppressed |
| Repatha Sureclick | Evolocumab | 19 | suppressed |
| Telmisartan-Amlodipine | Telmisartan/Amlodipine | 19 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 19 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 18 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 18 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 18 | 13 |
| Labetalol Hcl | Labetalol Hcl | 18 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 18 | suppressed |
| Brilinta | Ticagrelor | 17 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 17 | suppressed |
| Ramipril | Ramipril | 17 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 16 | suppressed |
| Estradiol | Estradiol | 16 | suppressed |
| Lidocaine | Lidocaine | 16 | suppressed |
| Nifedipine Er | Nifedipine | 16 | suppressed |
| Nystatin | Nystatin | 16 | suppressed |
| Olmesartan-Amlodipine-Hctz | Olmesartan/Amlodipin/Hcthiazid | 16 | suppressed |
| Ondansetron Odt | Ondansetron | 16 | 11 |
| Sumatriptan Succinate | Sumatriptan Succinate | 16 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 16 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 15 | suppressed |
| Belsomra | Suvorexant | 14 | suppressed |
| Ciclopirox | Ciclopirox | 14 | 11 |
| Ibu | Ibuprofen | 14 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 14 | suppressed |
| Irbesartan | Irbesartan | 13 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 13 | suppressed |
| Acarbose | Acarbose | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 12 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 12 | suppressed |
| Januvia | Sitagliptin Phosphate | 12 | suppressed |
| Linzess | Linaclotide | 12 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 12 | suppressed |
| Prolia | Denosumab | 12 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 12 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 12 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 11 | suppressed |
| Diazepam | Diazepam | 11 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 11 | 11 |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $339.93 · 5 records | VERTEX PHARMACEUTICALS INCORPORATED | Auvelity, JOURNAVX, REZDIFFRA, WATCHMAN FLX | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error